ArticleFrontiers in pharmacology2025

Real-world adverse event profile and signal characteristics of bevacizumab in glioma: a FAERS-based disproportionality analysis.

Mingyue Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.